The Pharma Rep Enablement Learning Journey with James Harper – Part 2

In the second installment of The Learning Journey podcast focusing on Pharma Rep Enablement, we continue the discussion around the evolution of the pharmaceutical sales representative and the impact it will have. James Harper, founder and managing director of Twentyeightb (28b), discusses what it means to enable reps with technology and why it is critical to do so. This episode …

The Pharma Rep Enablement Learning Journey with James Harper – Part 1

Over the last decade, there has been much discussion about the future of the pharma sales rep. Many people expected the switch to virtual information exchange forced by the pandemic to be the final nail in the coffin for sales reps; yet, companies have adopted hybrid models, virtual tools for customer engagement, and online sales training platforms – all of …

Episode 6: Pharma Sales – Today versus Tomorrow

Featuring: This episode features Rich Benedetto and Jeff Ainsworth. Rich is a former Sr. Executive Sales Representative at a global pharmaceutical company has over 35 years of experience in the pharmaceutical industry. Jeff is the VP of Global Sales and Business Development at ACTO. Jeff has nearly 15 years of experience as a sales leader and coach in the pharmaceutical …

eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …

ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group

Toronto, October 26, 2022: ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence (AI) by Everest Group, a leading global research firm focused exclusively on strategic IT, business process, and engineering services. In its  “Start-ups Creating Buzz in the Life Sciences Commercial Technology” 2022 market report,  Everest Group …

The Compliant Content Creation Learning Journey with Maria Bavishi

Content is king, but in our industry, that king must always be compliant. This is usually top of mind when writing and deploying market-facing materials, but how do you know they will stay current? How can you know whether the training and assets you produce continue to be engaging and actively used, which would assure you that your field team …

Our Story

Our storyHow did it all begin?Parth Khanna (Chief Executive Officer), Kapil Kalra (Chief Customer Officer), and Kumar Erramilli (Chief Technology Officer) met and were roommates as undergraduate students at the University of Waterloo. While they were each drawn to different academic studies, they shared a desire to make a positive impact on the world. After graduating, they each went their …

LTEN Focus Article: Driving the Evolution of Medical Affairs and MSLs

MSLs are under increasing pressure to provide complex scientific information to stakeholders. By Kristina BelyeaDirector of Content Marketing ACTO Over the past three years, there have been significant shifts and pivots in life sciences, including changes in how healthcare providers (HCPs)want to interact with pharmaceutical companies. This shift has made medical affairs and medical sciences liaisons (MSLs) increasingly crucial and …